Regado Biosciences Downsizes IPO, Seeks $42 Million

Published: Aug 20, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Apparently not everyone is having success pitching a biotech IPO to investors these days. Basking Ridge, NJ-based Regado Biosciences, the startup developing a two-pronged anticoagulant to be used in coronary procedures, is slashing the price of its IPO considerably. Regado initially aimed to raise $75 million by offering investors 5 million shares at between $14 and $16 apiece.

Help employers find you! Check out all the jobs and post your resume.

Back to news